Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Strategies and new developments to control pertussis, an actual health problem.

Literature DB >> 26260328

Strategies and new developments to control pertussis, an actual health problem.

María Emilia Gaillard¹, Daniela Bottero¹, Griselda Moreno², Martin Rumbo², Daniela Hozbor³.

Abstract

The aim of this article is to describe the current epidemiological situation of pertussis, as well as different short-term strategies that have been implemented to alleviate this threat. The state of the art of the development of new vaccines that are expected to provide long-lasting immunity against pertussis was also included. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords: epidemics; new vaccines; pertussis; short-term strategies

Mesh：

Substances：
Pertussis Vaccine

Year: 2015 PMID： 26260328 PMCID： PMC4626581 DOI： 10.1093/femspd/ftv059

Source DB: PubMed Journal: Pathog Dis ISSN： 2049-632X Impact factor: 3.166

87 in total

1. Pertussis vaccines: WHO position paper.

Authors:
Journal: Wkly Epidemiol Rec Date: 2010-10-01

2. Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells.

Authors: Viveka Schaar; Stefan P W de Vries; Maria Laura A Perez Vidakovics; Hester J Bootsma; Lennart Larsson; Peter W M Hermans; Anders Bjartell; Matthias Mörgelin; Kristian Riesbeck
Journal: Cell Microbiol Date: 2010-11-24 Impact factor: 3.715

3. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs.

Authors: Abdolreza Advani; Lennart Gustafsson; Christina Ahrén; Frits R Mooi; Hans O Hallander
Journal: Vaccine Date: 2011-03-09 Impact factor: 3.641

4. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2011-01-14 Impact factor: 17.586

5. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.

Authors: Maxwell A Witt; Paul H Katz; David J Witt
Journal: Clin Infect Dis Date: 2012-03-15 Impact factor: 9.079

6. Number and order of whole cell pertussis vaccines in infancy and disease protection.

Authors: Sarah L Sheridan; Robert S Ware; Keith Grimwood; Stephen B Lambert
Journal: JAMA Date: 2012-08-01 Impact factor: 56.272

7. The impact of additional pertussis vaccine doses on disease incidence in children and infants.

Authors: Chen Stein-Zamir; Hanna Shoob; Nitza Abramson; Gary Zentner
Journal: Vaccine Date: 2010-11-04 Impact factor: 3.641

Review 8. Immunity to the respiratory pathogen Bordetella pertussis.

Authors: R Higgs; S C Higgins; P J Ross; K H G Mills
Journal: Mucosal Immunol Date: 2012-06-20 Impact factor: 7.313

9. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.

Authors: Cristian J A Asensio; María Emilia Gaillard; Griselda Moreno; Daniela Bottero; Eugenia Zurita; Martin Rumbo; Peter van der Ley; Arno van der Ark; Daniela Hozbor
Journal: Vaccine Date: 2011-01-04 Impact factor: 3.641